TFF Pharmaceuticals Inc
NASDAQ:TFFP

  • LAST PRICE
    0.3769
  • TODAY'S CHANGE (%)
    -1.2231 (-76.4438%)
  • Bid / Lots
    0.3700/ 270
  • Ask / Lots
    0.3950/ 50
  • Open / Previous Close
    0.4000 / 1.6000
  • Day Range
    0.2700
    0.4640
  • 52 Week Range
    0.2700
    11.0000
  • Volume
    8,402,445

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
TFFP
TFF Pharmaceuticals Inc
5.5M
0.0x
---
AZTR
Azitra Inc
3.4M
0.0x
---
APM
Aptorum Group Ltd
6.2M
-0.8x
---
BDRX
Biodexa Pharmaceuticals PLC
2.8M
0.0x
---
ONCT
Oncternal Therapeutics Inc
3.3M
-0.1x
---
ADTX
Aditxt Inc
3.0M
0.0x
---
As of 2024-11-15

Company Information

TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaging patented rapid freezing technology to develop and transform medicine into potent dry powder. It is focused on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform. Its TFF technology platform has an applicability to convert any drug, including vaccines, small and large molecules, and biologics, into a dry powder for inhalation, or for topical delivery to the eyes, nose and the skin. TFF Pharmaceuticals has two lead drug candidates in the clinic: TFF TAC (Tacrolimus Inhalation Powder) and TFF VORI (Voriconazole Inhalation Powder). TFF TAC is an inhaled dry powder formulation of tacrolimus, for the prophylaxis of organ rejection in patients receiving lung transplants, in combination with other immunosuppressants. TFF VORI is an inhaled dry powder formulation of voriconazole, for the treatment and prophylaxis of invasive pulmonary aspergillosis.

Contact Information

Headquarters
2600 Via Fortuna Ste 360AUSTIN, TX, United States 78746-7983
Phone
---
Fax
302-655-5049

Executives

No data available

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$5.5M
Revenue (TTM)
$1.2M
Shares Outstanding
3.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.24
EPS
$-7.95
Book Value
$4.04
P/E Ratio
0.0x
Price/Sales (TTM)
4.6
Price/Cash Flow (TTM)
---
Operating Margin
-1,625.07%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.